Related Experiment Video
Updated: Oct 25, 2025

Using Caenorhabditis elegans to Screen for Tissue-Specific Chaperone Interactions
Published on: June 7, 2020
Interaction with the CCT chaperonin complex limits APOBEC3A cytidine deaminase cytotoxicity
Abby M Green1,2, Rachel A DeWeerd1, David R O'Leary1
1Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA.
Abstract:
The APOBEC3 cytidine deaminases are implicated as the cause of a prevalent somatic mutation pattern found in cancer genomes. The APOBEC3 enzymes act as viral restriction factors by mutating viral genomes. Mutation of the cellular genome is presumed to be an off-target activity of the enzymes, although the regulatory measures for APOBEC3 expression and activity remain undefined. It is therefore difficult to predict circumstances that enable APOBEC3 interaction with cellular DNA that leads to mutagenesis. The APOBEC3A (A3A) enzyme is the most potent deaminase of the family. Using proteomics, we evaluate protein interactors of A3A to identify potential regulators. We find that A3A interacts with the chaperonin-containing TCP-1 (CCT) complex, a cellular machine that assists in protein folding and function. Importantly, depletion of CCT results in A3A-induced DNA damage and cytotoxicity. Evaluation of cancer genomes demonstrates an enrichment of A3A mutational signatures in cancers with silencing mutations in CCT subunit genes. Together, these data suggest that the CCT complex interacts with A3A, and that disruption of CCT function results in increased A3A mutational activity.
Insights
The chaperonin-containing TCP-1 (CCT) complex regulates APOBEC3A (A3A) enzyme activity. Disruption of CCT function increases A3A-induced DNA damage and mutations, impacting cancer genomes.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- APOBEC3 cytidine deaminases cause somatic mutations in cancer genomes.
- APOBEC3 enzymes normally restrict viral genomes but can mutate cellular DNA.
- Regulation of APOBEC3 activity and cellular DNA interaction is poorly understood.
Purpose of the Study:
- To identify regulators of APOBEC3A (A3A) activity using proteomics.
- To investigate the role of protein interactors in A3A-mediated mutagenesis.
- To explore the link between CCT complex function and A3A mutational signatures in cancer.
Main Methods:
- Proteomic analysis to identify A3A protein interactors.
- Depletion studies to assess the impact of CCT complex on A3A activity.
- Bioinformatic evaluation of cancer genomes for mutational signatures.
Main Results:
- The chaperonin-containing TCP-1 (CCT) complex was identified as an A3A interactor.
- Depletion of CCT led to increased A3A-induced DNA damage and cytotoxicity.
- Cancer genomes showed enrichment of A3A mutational signatures in tumors with CCT gene mutations.
Conclusions:
- The CCT complex interacts with and likely regulates A3A activity.
- Disruption of CCT function enhances A3A-mediated mutagenesis.
- CCT complex dysfunction contributes to A3A mutational patterns in cancer.
More Related Videos
Related Concept Videos
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Anaphase Promoting Complex
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
Inhibition of Cdk Activity
RNA Editing
The Intrinsic Apoptotic Pathway

